Clinical Trials

At Blueberry Therapeutics

Clinical Trials

Blueberry Therapeutics Ongoing Clinical Trials

Study title (code) Locations Status Further information
Multi-centre, international, randomised, vehicle controlled, parallel-group, double-blinded Phase 2 trial of BB2603 topical treatment in subjects with distal subungual onychomycosis (DSO) of the toenail (BBTAF202). Europe (Germany, Poland, Czech Republic) Completed Click here for information on this clinical trial
Early phase development, partly blinded, positive and vehicle controlled, randomised, non-inferiority investigation of the pharmacokinetics, safety and efficacy of BB2603 cutaneous hand-pump spray versus Lamisil® spray and versus BB2603 vehicle hand-pump spray in subjects with onychomycosis and associated tinea pedis (BBT120126032001). Germany Completed

for the results of this trial